DE-117 Spectrum 5

DE-117 Spectrum 5 · Santen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-117 Spectrum 5, covering 2023-08-30 to 2023-08-30. Get the full timeline:

Most recent: Clinical Trial Update: DE-117 Spectrum 5 Study [Phase 3]